Placebo Tablet for OG-6219 clinical trials

A Phase 2a/b, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Clinical Study to Evaluate the Efficacy and Safety of OG-6219 in 3 Dose Levels, in Women 18 to 49 Years of Age with Moderate to Severe Endometriosis-related Pain

This study is testing a new tablet, OG-6219, for women aged 18-49 experiencing moderate to severe pain from endometriosis. It will compare different doses against a dummy pill to see how well it works and if it's safe.